What is Plasma therapy and can it cure coronavirus?

What is Plasma therapy and can it cure coronavirus?

What is Plasma therapy and can it cure coronavirus?

Many countries in the whole world are trying to find medicine to cure coronavirus including India. The whole world is thinking that plasma therapy has the potential to cure the disease COVID-19 caused by the novel coronavirus. In plasma therapy the blood donated by a recovered person of Coronavirus into the infected person to introduce antibodies that can fight coronavirus.

Plasma Therapy

As pandemic of coronavirus continues across the globe many country scientists trying to develop vaccines and medicines for the unknown coronavirus. Scientists and researchers are trying to find various ways to come up with the unending pandemic of Coronavirus. One treatment is on the rise right now which is convalescent Plasma therapy.


  After China and the USA India is also moving ahead towards convalescent plasma therapy and making a plan to conduct the trial. The convalescent plasma therapy has been used in the past so it gives hope that it can cure coronavirus.

What is convalescent Plasma therapy? Can it treat coronavirus?

Scientists and researchers are testing to use the donated blood as the treatment for the people who are infected with coronavirus disease. The person who is recovered with the Coronavirus has developed antibodies against the virus in their blood doctor call this the convalescent plasma. It is considered as a hope that by transferring the blood with antibodies to the infected person can help him to increase his ability against the virus.


   Doctors must ensure that before the blood is donated it must be tested for safety and it then undergoes a process in which the blood cells are separated so that there is only plasma left in it with antibodies. The convalescent plasma therapy has given hope and a chance to recover the infected people but it’s not sure that it will improve the condition of the person or it will make him sicker.


What is Plasma?

Plasma is the liquid portion of the whole blood. It is largely composed of protein and water, it provides medium for red blood cells and white blood cells and the platelets to circulate through the body.

How convalescent plasma therapy works?

Convalescent plasma therapy uses the blood in which antibodies are present when a person is infected with the Coronavirus and recover then it developed antibodies in her/his body.


  The antibodies generated patient as a part of the body is a natural immune response to an introduced pathogen. Once the antibodies created against a specific virus then it works on it and eliminates it. Once the patient has recovered then he or she can donate their blood so that their antibodies can be used to treat the infected person.


Convalescent Plasma therapy likely to begin from April 25 in Karnataka:

Karnataka is likely to start the convalescent plasma therapy for serious coronavirus patients, Medical Education Minister K Sudhakar said on Friday that they have got the approval for convalescent Plasma therapy and there is no need of special permission for it. The donor has also agreed. He also said that the convalescent plasma therapy is only for the person who is in critical condition on a ventilator.

Convalescent plasma therapy shows the positive result on COVID-19 patient:

Delhi CM Arvind Kejriwal said that plasma therapy shows a positive result for the patient in the capital. For Corona virus-positive patient ahead plasma therapy treatment in Delhi Lok Nayak Jai Prakash Narayan Hospital in the last few weeks. The results were positive and encouraging for the treatment of the Coronavirus. 

   A 49-year-old male, the first Coronavirus patient who was treated with the plasma therapy in the Max Hospital, Saket, had also shown positive results and he is now off for ventilator support. Kerala, Gujarat, Punjab also started using plasma therapy to cure coronavirus patient and the Delhi government is now planning to ask the central government to allow plasma therapy in the states with critical patients.